title: Synthesis, analysis and cytotoxic evaluation of some hydroxypyridinone derivatives on HeLa and K562 cell lines.
abstract: A range of iron bidentae ligands containing the chelating moiety 3- hydroxypyridin-4-ones (HPOs) have been synthesized via a single or a three-step synthetic pathway. In the single-step reaction, maltol was directly reacted by suitable primary amine and in the second synthetic method; benzylated maltol was reacted with related amines to give 1-substuted-2-methyl-3-benzyloxypyridin-4-one derivatives. Finally, removal of the benzyl group under acidic conditions was performed by catalytic hydrogenation to yield the favored bidentate chelators as HCl salt. The partition coefficient of the free ligands and their iron (III) complexes between an aqueous phase buffered at pH 7.4 and 1-octanol were also determined. The cytotoxic effects of these iron chelators against HeLa and K562 cell lines were evaluated using MTT assay and the results showed that cytotoxicity was closely related to the lipophilicity of compounds so that the most lipophilic compound (4g) revealed the highest activity and compound 4e as a more hydrophilic agent (Kpart; 0.05) showed the lowest cytotoxic effect.
authors.affiliation: Department of Pharmaceutical Chemistry andIsfahan Pharmaceutical Research Centre, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, I.R. Iran.
authors.forename: L
authors.initials: L
authors.lastname: Saghaie
authors.forename: H
authors.initials: H
authors.lastname: Sadeghi-Aliabadi
authors.forename: M
authors.initials: M
authors.lastname: Ashaehshoar
keywords: 3-Hydroxypyridin-4-ones; Cytotoxicity; HeLa and K562 cells; Iron chelating agents; Lipophilicity
references.citation: Arzneimittelforschung. 1994 Apr;44(4):522-6
references.pmid: 8011008
references.citation: Lancet. 1989 Jun 17;1(8651):1399-400
references.pmid: 2567424
references.citation: Farmaco. 2004 Aug;59(8):645-9
references.pmid: 15262534
references.citation: J Biol Chem. 1996 Apr 5;271(14):7965-72
references.pmid: 8626476
references.citation: J Biol Chem. 1996 Aug 23;271(34):20291-9
references.pmid: 8702762
references.citation: Bioorg Med Chem Lett. 1999 Oct 18;9(20):3035-40
references.pmid: 10571171
references.citation: Free Radic Biol Med. 1996;20(4):553-66
references.pmid: 8904296
references.citation: Blood. 1992 Jan 1;79(1):248-53
references.pmid: 1728313
references.citation: J Med Chem. 1993 Aug 20;36(17):2448-58
references.pmid: 8355246
references.citation: Proc Natl Acad Sci U S A. 1994 Aug 16;91(17):7903-6
references.pmid: 8058732
references.citation: Breast Cancer Res Treat. 2001 Sep;69(1):69-79
references.pmid: 11759830
references.citation: Res Pharm Sci. 2011 Jul;6(2):117-22
references.pmid: 22224095
references.citation: FEBS Lett. 1994 Aug 15;350(1):139-42
references.pmid: 8062913
references.citation: Blood. 1991 May 1;77(9):2049-53
references.pmid: 2018841
references.citation: Cancer Res. 2001 Feb 1;61(3):1073-9
references.pmid: 11221835
references.citation: Blood. 1988 Nov;72(5):1497-503
references.pmid: 3179437
references.citation: Clin Cancer Res. 2001 Nov;7(11):3574-9
references.pmid: 11705879
references.citation: Eur J Med Chem. 2008 May;43(5):1035-47
references.pmid: 17869385
references.citation: Eur J Med Chem. 2009 May;44(5):2145-57
references.pmid: 19056147
references.citation: J Leukoc Biol. 2004 Jul;76(1):169-75
references.pmid: 15075348
references.citation: Curr Top Med Chem. 2004;4(15):1623-35
references.pmid: 15579100
references.citation: Biochemistry. 1992 Nov 24;31(46):11255-64
references.pmid: 1445865
references.citation: Blood. 1990 Dec 1;76(11):2389-96
references.pmid: 2257308
references.citation: Science. 1994 Aug 12;265(5174):936-7
references.pmid: 8052849
references.citation: Br J Haematol. 1986 Apr;62(4):607-13
references.pmid: 3964556
references.citation: Hemoglobin. 1988;12(5-6):593-600
references.pmid: 3209401
references.citation: Scand J Haematol. 1986 Jul;37(1):63-70
references.pmid: 3764334